GNPX
Price:
$2.02
Market Cap:
$5.23M
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.[Read more]
Industry
Biotechnology
IPO Date
2018-03-29
Stock Exchange
NASDAQ
Ticker
GNPX
According to Genprex, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.13. This represents a change of -68.96% compared to the average of -0.42 of the last 4 quarters.
The mean historical PE Ratio of Genprex, Inc. over the last ten years is -5.83. The current -0.13 PE Ratio has changed 122.90% with respect to the historical average. Over the past ten years (40 quarters), GNPX's PE Ratio was at its highest in in the June 2024 quarter at -0.16. The PE Ratio was at its lowest in in the December 2016 quarter at -43.61.
Average
-5.83
Median
-3.15
Minimum
-16.28
Maximum
-0.41
Discovering the peaks and valleys of Genprex, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.61%
Maximum Annual PE Ratio = -0.41
Minimum Annual Increase = -92.49%
Minimum Annual PE Ratio = -16.28
Year | PE Ratio | Change |
---|---|---|
2023 | -0.41 | -82.72% |
2022 | -2.36 | -25.09% |
2021 | -3.15 | -61.72% |
2020 | -8.22 | 1.61% |
2019 | -0.48 | -60.72% |
2018 | -1.22 | -92.49% |
2017 | -16.28 | 32.53% |
2016 | -12.28 | 51.95% |
The current PE Ratio of Genprex, Inc. (GNPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.97
5-year avg
-2.92
10-year avg
-5.83
Genprex, Inc.’s PE Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (-1.05), greater than Greenwich LifeSciences, Inc. (-16.53), greater than Cognition Therapeutics, Inc. (-0.61), greater than Gracell Biotechnologies Inc. (-12.30), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.05), greater than Eyenovia, Inc. (-0.74), greater than TransCode Therapeutics, Inc. (-0.20), greater than Kodiak Sciences Inc. (-1.04), less than eFFECTOR Therapeutics, Inc. (0), less than X4 Pharmaceuticals, Inc. (-0.00), less than Elevation Oncology, Inc. (6.04), greater than Mereo BioPharma Group plc (-0.78), greater than Hepion Pharmaceuticals, Inc. (-16.88), less than null (-0.13),
Company | PE Ratio | Market cap |
---|---|---|
-1.05 | $33.39M | |
-16.53 | $172.06M | |
-0.61 | $19.04M | |
-12.30 | $989.87M | |
-1.05 | $36.43M | |
-0.74 | $44.32M | |
-0.20 | $8.89M | |
-1.04 | $205.20M | |
0 | $1.88K | |
-0.00 | $89.59M | |
6.04 | $30.89M | |
-0.78 | $616.59M | |
-16.88 | $3.68M | |
-0.13 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genprex, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genprex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genprex, Inc.'s PE Ratio?
How is the PE Ratio calculated for Genprex, Inc. (GNPX)?
What is the highest PE Ratio for Genprex, Inc. (GNPX)?
What is the 3-year average PE Ratio for Genprex, Inc. (GNPX)?
What is the 5-year average PE Ratio for Genprex, Inc. (GNPX)?
How does the current PE Ratio for Genprex, Inc. (GNPX) compare to its historical average?